042520 Stock Chart & Stats
₩17010.00
-₩2,490.00(-12.77%)
―
--
Day’s Range― - ―
52-Week Range₩6,970.00 - ₩57,800.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)204.96K
Market Cap
₩233.41B
Enterprise Value₩344.44K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Feb 17, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)135.47
Shares Outstanding14,261,367
10 Day Avg. Volume182,115
30 Day Avg. Volume204,959
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
042520 FAQ
What was Hans Biomed Corp’s price range in the past 12 months?
Hans Biomed Corp lowest stock price was ₩6970.00 and its highest was ₩57800.00 in the past 12 months.
What is Hans Biomed Corp’s market cap?
Hans Biomed Corp’s market cap is ₩233.41B.
When is Hans Biomed Corp’s upcoming earnings report date?
Hans Biomed Corp’s upcoming earnings report date is Feb 17, 2027 which is in 178 days.
How were Hans Biomed Corp’s earnings last quarter?
Hans Biomed Corp released its earnings results on Aug 19, 2026. The company reported ₩135.473 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Hans Biomed Corp overvalued?
According to Wall Street analysts Hans Biomed Corp’s price is currently Undervalued.
Does Hans Biomed Corp pay dividends?
Hans Biomed Corp does not currently pay dividends.
What is Hans Biomed Corp’s EPS estimate?
Hans Biomed Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hans Biomed Corp have?
Hans Biomed Corp has 14,261,367 shares outstanding.
What happened to Hans Biomed Corp’s price movement after its last earnings report?
Hans Biomed Corp reported an EPS of ₩135.473 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.251%.
Which hedge fund is a major shareholder of Hans Biomed Corp?
Currently, no hedge funds are holding shares in KR:042520
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dentium Co., Ltd.
―
HUMEDIX Co.LTD.
―
EuBiologics Co., Ltd.
―
Curocell, Inc.
―
Nextbiomedical Co. Ltd.
―